Lisanne E N Manson

The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen.

H. Guchelaar, J. Swen, C. H. van der Wouden, 2017, Pharmacogenomics.

Genotyping for HLA Risk Alleles to Prevent Drug Hypersensitivity Reactions: Impact Analysis

W. B. van den Hout, Henk-Jan Guchelaar, Lisanne E N Manson, 2021, Pharmaceuticals.

Genotyping for HLA risk alleles versus patch tests to diagnose anti-seizure medication induced cutaneous adverse drug reactions

S. Böhringer, Lisanne E N Manson, H. Guchelaar, 2022, Frontiers in Pharmacology.

Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines

H. Guchelaar, J. Swen, Lisanne E N Manson, 2020, Frontiers in Pharmacology.

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

M. Pirmohamed, A. Cambon-Thomsen, Yitian Zhou, 2023, The Lancet.